Viatris Inc

NASDAQ:VTRS   4:00:00 PM EDT
8.93
-0.08 (-0.89%)
6:38:50 PM EDT: $8.93 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.48B
Current PEN/A
Forward PE 4
2yr Forward PE 3.67
See more stats
Estimates Current Quarter
Revenue$3.47 Billion
Adjusted EPS$0.55
See more estimates
10-Day MA$8.93
50-Day MA$8.56
200-Day MA$10.24
See more pivots

Viatris Inc Stock, NASDAQ:VTRS

Robert J. Coury Global Center, 1000 Mylan Boulevard, Canonsburg, Pennsylvania 15317
United States of America
Phone: +1.724.514.1800
Number of Employees: 32000

Description

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.